Mira Pharmaceuticals Files 8-K
Ticker: MIRA · Form: 8-K · Filed: Oct 16, 2025 · CIK: 1904286
| Field | Detail |
|---|---|
| Company | Mira Pharmaceuticals, Inc. (MIRA) |
| Form Type | 8-K |
| Filed Date | Oct 16, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $0, $2.19, $3,835,485 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-event, disclosure
TL;DR
Mira Pharma filed an 8-K, but details are scarce. Keep an eye out for more info.
AI Summary
Mira Pharmaceuticals, Inc. filed an 8-K on October 16, 2025, reporting an "Other Events" item. The filing does not contain specific details about the event itself but confirms the company's principal executive offices are located at 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida. The company was formerly known as Mira1a Therapeutics, Inc., with a name change effective January 12, 2022.
Why It Matters
This 8-K filing indicates a corporate event has occurred, requiring disclosure to investors. However, the lack of specific details in this filing means further information is needed to understand the event's impact.
Risk Assessment
Risk Level: low — The filing is procedural and lacks specific financial or operational details that would typically indicate high risk.
Key Players & Entities
- MIRA PHARMACEUTICALS, INC. (company) — Registrant
- Mira1a Therapeutics, Inc. (company) — Former company name
- October 16, 2025 (date) — Date of report
- 1200 Brickell Avenue, Suite 1950 #1183 Miami, Florida 33131 (address) — Principal executive offices
FAQ
What specific event triggered this 8-K filing?
The filing is categorized under 'Other Events' but does not specify the exact event that necessitated the report.
When was the company's name officially changed?
The company's name was changed from Mira1a Therapeutics, Inc. to Mira Pharmaceuticals, Inc. on January 12, 2022.
Where are Mira Pharmaceuticals' principal executive offices located?
The principal executive offices are located at 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131.
What is Mira Pharmaceuticals' IRS Employer Identification Number?
The IRS Employer Identification Number for Mira Pharmaceuticals, Inc. is 85-3354547.
What is the company's SIC code?
The Standard Industrial Classification code for Mira Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 439 words · 2 min read · ~1 pages · Grade level 12.1 · Accepted 2025-10-16 16:01:54
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share MIRA The Nasdaq
- $0 — 0 shares of its common stock, par value $0.001, in block sales to multiple institu
- $2.19 — ional investors, at an average price of $2.19 share (a 66% premium to the prior days
- $3,835,485 — from the Offering totaled approximately $3,835,485 prior to deducting fees and expenses. T
Filing Documents
- form8-k.htm (8-K) — 35KB
- 0001493152-25-018303.txt ( ) — 198KB
- mira-20251016.xsd (EX-101.SCH) — 3KB
- mira-20251016_lab.xml (EX-101.LAB) — 33KB
- mira-20251016_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MIRA PHARMACEUTICALS, INC. Dated: October 16, 2025 By: /s/ Erez Aminov Name: Erez Aminov Title: Chief Executive Officer